OSG, US0231398845

Octave Specialty Group schedules third-quarter results for Octave Specialty Group stock

Published on 10/21/2026 at 00:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Third-quarter results are due November 9, 2026, after Q2 revenue reached USD 83.00 million. A USD 11.50 target frames Octave Specialty Group stock.

Operating dates and earnings

  • Third-quarter results are scheduled for November 9, 2026, with a conference call on November 10, 2026.
  • Second-quarter revenue reached USD 83.00 million, while adjusted loss per share was USD 0.04.
  • Five analysts held a consensus target of USD 11.50 on October 17, 2026.
OSG, US0231398845, Illustration mit AI erstellt.

Octave Specialty Group (ISIN US0231398845) scheduled its third-quarter 2026 results for November 9, 2026, followed by a conference call on November 10, 2026, according to Fidelity on October 19, 2026. The announcement gives investors a fixed date for the next test of the specialty insurer's growth strategy.

Three dates define the story

On August 6, 2026, Octave reported second-quarter revenue of USD 83.00 million and an adjusted loss per share of USD 0.04, according to MarketBeat. On October 8, 2026, its Pivix business launched a commercial property program available in 20 states, with coverage of up to USD 4.00 million at one location and schedules of up to USD 10.00 million, as StockTitan reported. On October 19, 2026, Octave set November 9, 2026, for its third-quarter results.

What does the growth plan mean?

The second-quarter update paired faster distribution growth with lower near-term earnings expectations. Zacks reported that 2026 Insurance Distribution organic growth guidance increased to at least 25.00 percent from at least 20.00 percent, while adjusted EBITDA guidance rose to USD 45.00 million from USD 40.00 million. At the same time, adjusted net income per share guidance was reduced to USD 0.15-0.20 from USD 0.50, leaving the November report to clarify whether distribution gains can offset pressure elsewhere.

Two November dates matter

The company is scheduled to release third-quarter results on November 9, 2026, after the market close, and management is scheduled to discuss them at 8:30 a.m. ET on November 10, 2026, according to Fidelity. The call should provide the next quantified view of MGA launches, distribution margins and Everspan's path toward scale.

Valuation remains a key counterweight

Octave's market capitalization was USD 209.70 million on October 17, 2026, while its one-year range was USD 3.88 to USD 10.38. MarketBeat listed a consensus Hold rating from five firms and an average 12-month target of USD 11.50 on October 17, 2026. The combination of a scheduled earnings date, revised guidance and a wide valuation debate makes the November release the next material checkpoint.

Octave Specialty Group at a glance

  • Company: Octave Specialty Group, Inc.
  • ISIN: US0231398845
  • Ticker: OSG
  • Primary exchange: NYSE
  • Market capitalization: USD 209.7 million (as of October 17, 2026)
  • 52-week range: USD 3.88-10.38 (as of October 17, 2026)
  • Sector / Industry: Financial Services / Insurance - Specialty

Market context: Market report S&P 500.

More news and analyses on Octave Specialty Group stock

Disclaimer...
en | US0231398845 | OSG | boerse | 70378721 | bgmi